Evidence map›Paper›PMID 37072164›Full record

ArticleRespiratory care2023

Etiologies and Outcome of Patients with Solid Tumors Admitted to ICU with Acute Respiratory Failure: A Secondary Analysis of the EFRAIM Study.

Soraya Benguerfi, Guillaume Dumas, Marcio Soares, Anne-Pascale Meert, Ignacio Martin-Loeches, Frederic Pene, Philippe Bauer, Sangeeta Mehta, Victoria Metaxa, Gaston Burghi and 7 more

Open access · greenAbstract read
In one paragraph

Article in Respiratory care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Acute neurological dysfunction in critically ill patients with solid tumors: A 14-year retrospective study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 13 institutions in 9 countries.

Soraya BenguerfiDepartment of Intensive-Resuscitation Medicine, APHP, Hôpital Saint-Louis, Paris Diderot Sorbonne Université, Paris, France. Soraya.benguerfi@gmail.com.
Guillaume DumasDepartment of Intensive-Resuscitation Medicine, APHP, Hôpital Saint-Louis, Paris Diderot Sorbonne Université, Paris, France.
Marcio SoaresDepartment of Critical Care and Graduate Program in Translational Medicine, D'Or Institute for Research and Education, Programa de Pós-Graduaçãoem Clínica Médica, Rio De Janeiro, Brazil.
Anne-Pascale MeertInternal Medicine Service, Soins Intensifs & Urgences Oncologique, Institut Jules Bordet, Brussels, Belgium.
Ignacio Martin-LoechesDepartment of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization, St James's Hospital, Dublin, Ireland.
Frederic PeneMedical ICU, Cochin Hospital, Assistance Publique-Hôpitaux de Paris and Paris Descartes University, Paris, France.
Philippe BauerPulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.
Sangeeta MehtaDepartment of Medicine, Sinai Health System, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
Victoria MetaxaDepartment of Critical Care, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Gaston BurghiTerapia Intensiva, Hospital Maciel, Montevideo, Uruguay.
Achille KouatchetDepartment of Medical Intensive Care Medicine, University Hospital of Angers, Angers, France.
Luca MontiniDepartment of Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
Djamel MokartMultipurpose Resuscitation Service and Department of Anesthesia and Resuscitation, Institut Paoli-Calmettes, Marseille, France.
Andry Van de LouwDivision of Pulmonary and Critical Care Medicine, Penn State University College of Medicine, Hershey, Pennsylvania.
Elie AzoulayDepartment of Intensive-Resuscitation Medicine, APHP, Hôpital Saint-Louis, Paris Diderot Sorbonne Université, Paris, France.
Virginie LemialeDepartment of Intensive-Resuscitation Medicine, APHP, Hôpital Saint-Louis, Paris Diderot Sorbonne Université, Paris, France.
EFRAIM investigators and Nine-I study group
Délégation Paris 7 · FRAgostino Gemelli University Polyclinic · ITDélégation Paris 5 · FRD’Or Institute for Research and Education · BRHospital Maciel · UYInstitut Jules Bordet · BEInstitut Paoli-Calmettes · FRKing's College Hospital NHS Foundation Trust · GBMayo Clinic · USPenn State Milton S. Hershey Medical Center · USSt. James's Hospital · IEUniversité d'Angers · FRUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute respiratory failure (ARF) remains the most frequent reason for ICU admission in patients who are immunocompromised. This study reports etiologies and outcomes of ARF in subjects with solid tumors.

methodsThis study was a post hoc analysis of the EFRAIM study, a prospective multinational cohort study that included 1611 subjects who were immunocompromised and with ARF admitted to the ICU. Subjects with solid tumors admitted to the ICU with ARF were included in the analysis.

resultsAmong the subjects from the EFRAIM cohort, 529 subjects with solid tumors (32.8%) were included in the analysis. At ICU admission, the median (interquartile range) Sequential Organ Failure Assessment score was 5 (3-9). The types of solid tumor were mostly lung cancer (

conclusionsInfectious diseases remained the most frequent cause of ARF in subjects with solid tumors admitted to the ICU. Hospital mortality was related to severity at ICU admission, previous comorbidities, and ARF etiologies related to non-malignant causes or pulmonary embolism. Lung tumor was also independently associated with higher mortality.

Indexed as

Lung NeoplasmsRespiratory InsufficiencyCohort StudiesHospital MortalityHumansIntensive Care UnitsProspective Studiescritical care outcomesICUlung neoplasmsmedical oncologyneoplasmsrespiratory insufficiency

Identifiers

PMID37072164
PMCPMC10209001
OpenAlexW4366265700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.